JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
JAVMA news
$4.8M grant funds work on vaccine for coccidioidomycosis
The National Institutes of Health has awarded a four-year, $4.8 million grant to the University of Arizona College of Medicine-Tucson to fund work on
JAVMA news
Taking on cancer
Cancer is a leading cause of death in dogs and cats—particularly now that more pets are living long enough to develop the disease.
JAVMA news
Nominations open for AVMA Excellence Awards
The nomination period for the following AVMA Excellence Awards is now open.
JAVMA news
Foundation receives $1M grant for osteosarcoma research
The Petco Foundation and the Blue Buffalo Foundation have partnered to sponsor a $1 million grant for Morris Animal Foundation to help fund research…